No Data
Even with the start of the new fiscal year, active buying of leading stocks is likely to continue to be restrained.
This week, trading will primarily focus on short-term investments in bio-related stocks and IPOs as the new fiscal year begins. However, due to the implementation of additional tariffs by the US on April 2, along with strong concerns about the subsequent impact on the real economy, it is believed that active buying cannot be expected given the prevailing uncertainty. The Emerging Markets, centered on domestic demand, seem to be relatively stable compared to the Main Board market, but there is no feeling that the main indices in the Growth market will rise significantly. The Growth Market 250 Index has narrowed its gains.
Trial Holdings: Extraordinary Report
The trading of major stocks may decrease, leading short-term funds to flow towards IPOs.
■ Since March 27 is the last day to hold rights for Dividends and benefits, interest is expected to turn towards Large Cap stocks in the Main Board, which may lead to a decrease in trading of key stocks in the Emerging Markets. On the other hand, the Growth Market 250 Index is clearly above the 25-day moving average, despite facing resistance at higher levels. It appears that a situation can be expected where attention is focused on the recent high of 693.92 points (February 13).
Continuing to rise, attempting to recover against the background of buy on dips, ETC.
Overview of the previous week from March 17 to March 21, Tokyo Stock Exchange Growth Index High: 672.42 Low: 657.81 Close: 667.1 compared to the previous week: 1.19% ↑ continued rise, trying to recover supported by bargain hunting and other factors. It showed a trend of attempting recovery supported by bargain buying. Among individual stocks, a portion of biotech-related stocks such as Perseus Proteomics <4882> and Sanbio <4592> showed movement. However, large Market Cap stocks such as Trial HD <141A> and Integral <5842>.
Growth 250 has risen for three consecutive days, with Drone-related stocks increasing in Emerging Markets on the 18th.
The Tokyo Stock Exchange Growth Market 250 Index has risen for three consecutive days. While the Tokyo market as a whole continues its rebound, the Emerging Markets have also shown solid performance. Stocks such as Cover <5253.T>, Genda <9166.T>, and Heartseed <219A.T> have increased. Drone-related companies like ACSL <6232.T>, Terra Drone <278A.T>, and Liberaware <218A.T> have seen a significant rise. Trial Holdings <141A.T> is trading lower. IPO (initial public offering)
Trial, Mincab [Emerging Markets Rating List]
"Daiwa" <141A> Trial 2 Hold "Tokai Tokyo" <4436> Mincub NEUTRAL Hold * The ratings of the above companies are based on our confirmation as of March 17.
See the daily top gainer.